The Regeneron CEO says other countries need to pay more and that the company understands 'MFN' will apply to new products, because in many cases, the US company does not control pricing in other markets.
Regeneron CEO says other countries need to pay more and 'MFN' will not be easy
August 4, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Ferronova secures funding to advance nanoparticle technology for cancer surgery
December 17, 2025 - - Australian Biotech -
Antimalarial candidate under WEHI-MSD partnership offers fresh hope against resistance
December 17, 2025 - - Latest News -
OncoSil completes first production run at new Sydney manufacturing facility
December 17, 2025 - - Australian Biotech -
Budget update repeats the 'fiscal illusion' that has become PBS spending
December 17, 2025 - - Latest News -
Island Pharmaceuticals secures key partnership with Texas Biomed
December 17, 2025 - - Australian Biotech -
Novartis names new Country President following leadership transition
December 16, 2025 - - Latest News -
Mayne Pharma opens expanded manufacturing facility after termination of takeover
December 16, 2025 - - Latest News

